Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
Benjamin Hanfstein(Heidelberg University), Frank Stegelmann(University Hospital Ulm), Susan Branford(South Australia Pathology), Karsten Spiekermann(German Cancer Research Center), Susanne Saußele(University of Mannheim), Michael Pfreundschuh(Saarland University), Rüdiger Hehlmann(Heidelberg University), Hermann Einsele(Universitätsklinikum Würzburg), Jolanta Dengler(Heidelberg University), Claudia Haferlach(Munich Leukemia Laboratory (Germany)), Andreas Hochhaus(Jena University Hospital), Philipp Erben(Heidelberg University), Christiane Falge(Nuremberg Hospital), Andreas Neubauer(RWTH Aachen University), Timothy P. Hughes(Royal Adelaide Hospital), Cornelius F. Waller(University Medical Center Freiburg), Marc Müller(Heidelberg University), Mathias Hänel(Klinikum Chemnitz), Michael Kneba(Universitäts Hautklinik Kiel), Markus Pfirrmann(Ludwig-Maximilians-Universität München), Michael Lauseker(Zimmer Biomet (Germany)), Gudrun Göhring(Medizinische Hochschule Hannover), Stefan W. Krause(Universitätsklinikum Erlangen), Gabriela M. Baerlocher(Terry Fox Research Institute), Joerg Hasford(Ludwig-Maximilians-Universität München), Ulrike Proetel(Heidelberg University), Susanne Schnittger(Goethe University Frankfurt), H-J Kolb(LMU Klinikum), Lothar Kanz(University of Freiburg), W.‐K. Hofmann(Heidelberg University), Alice Fabarius(Heidelberg University), Jörg Schubert(Saarland University)
Cited by 417
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k